Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vivitrol dosing and administration
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Response to "Glucocorticoids for treating Takotsubo syndrome?" and "Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis".
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
Multiple sclerosis causing a partial sixth nerve palsy.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Mutations affecting segment number and polarity in Drosophila.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
Patient perceptions of multiple sclerosis and its treatment.
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Pages
« first
‹ previous
…
164
165
166
167
168
169
170
171
172
…
next ›
last »